SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-023244
Filing Date
2017-11-09
Accepted
2017-11-09 16:15:20
Documents
62
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alrn-10q_20170930.htm 10-Q 2047680
2 EX-31.1 alrn-ex311_7.htm EX-31.1 14239
3 EX-31.2 alrn-ex312_6.htm EX-31.2 14230
4 EX-32.1 alrn-ex321_8.htm EX-32.1 7886
5 EX-32.2 alrn-ex322_9.htm EX-32.2 6943
  Complete submission text file 0001564590-17-023244.txt   6788935

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alrn-20170930.xml EX-101.INS 1401937
7 XBRL TAXONOMY EXTENSION SCHEMA alrn-20170930.xsd EX-101.SCH 44838
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrn-20170930_cal.xml EX-101.CAL 32572
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrn-20170930_def.xml EX-101.DEF 138938
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20170930_lab.xml EX-101.LAB 344680
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20170930_pre.xml EX-101.PRE 275383
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38130 | Film No.: 171191016
SIC: 2834 Pharmaceutical Preparations